• Tiamulin (Thiamutilin): Mechanism and Use

  2026-09-28

  Tiamulin, also called Thiamutilin, is a pleuromutilin antibiotic for veterinary control of respiratory and enteric infections in pigs and poultry. Its 50S-ribosome binding, species-dependent metabolism, and residue limits define how researchers should interpret antimicrobial, pharmacokinetic, and anti-inflammatory data.

• Mitochondrial Calcium Signaling Restrains Ferroptosis

  2026-09-28

  The study links mitochondrial calcium uptake through MCU to acetyl-CoA-dependent GPX4 acetylation, identifying a metabolic route that helps sustain GPX4 activity and suppress ferroptosis. Genetic rescue, mutagenesis, structural analysis, and tumor experiments connect this pathway to organismal survival and cancer growth, while also defining questions for follow-up work.

• α2-AR Agonism: From Receptor Biology to OS Research

  2026-09-27

  A translational perspective on α2-adrenergic receptor agonism in osteosarcoma recurrence research, integrating recent immune-microenvironment findings with practical guidance for rigorous preclinical studies.

• Tamsulosin for Cell Assays: A Practical Research Guide

  2026-09-26

  This scenario-based guide explains how to use Tamsulosin (SKU C6445) as a biological perturbation in cell viability and receptor-signaling research—not as a viability reagent. It connects assay controls and solvent handling with product formulation details and the limits of clinical evidence.

• Tolazoline Workflows for Receptor and Islet Studies

  2026-09-25

  Tolazoline supports controlled dissection of α2-adrenergic receptor signaling, with a separate, concentration-sensitive effect on pancreatic β-cell KATP channels. This practical guide connects airway and islet workflows to a brain-insulin-signaling study without implying that Tolazoline has demonstrated efficacy in Alzheimer’s disease.

• Alfuzosin HCl for α1 Receptor Research

  2026-09-25

  Build BPH-focused experiments around Alfuzosin HCl with workflows that connect α1-receptor pharmacology to smooth-muscle function and analytical verification. The article also shows how to borrow rigorous endpoint design from UTI trials without confusing an antibiotic study with evidence for alfuzosin efficacy.

• Lamotrigine in Epilepsy and Cardiac Assays

  2026-09-24

  Build interpretable Lamotrigine studies with a practical workflow for sodium-channel assays, epilepsy models, and cardiac electrophysiology. The guide separates product-reported activity from suggested starting conditions and shows how orthogonal readouts can prevent overinterpreting a single assay.

• Dorsomorphin 2HCl: AMPK Inhibitor Guide

  2026-09-24

  Dorsomorphin 2HCl is an AMPK inhibitor used to test pathway involvement, but it also inhibits BMP signaling through BMP type I receptors. In a mouse model of alcohol-induced hepatic lipid accumulation, dorsomorphin treatment weakened the benefits associated with Lactiplantibacillus plantarum P101, supporting AMPK involvement without establishing a treatment effect in humans.

• EV-Transferred ACLY Reprograms Macrophages in HCC

  2026-09-23

  The study identifies extracellular vesicle (EV)-transferred ATP-citrate lyase (ACLY) as a metabolic signal that helps convert monocytes into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered vesicle experiments support a causal role for ACLY and suggest that selectively targeting this pathway may improve checkpoint immunotherapy, while leaving important questions about clinical translation and broader tumor relevance.

• Epinephrine Bitartrate: Adrenergic Research Guide

  2026-09-23

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist for controlled α- and β-receptor activation in cell, cardiovascular, and translational studies. Product specifications and a canine pharmacokinetic study support distinct research-use benchmarks, but canine intranasal exposure does not establish human dose equivalence.

• CSBTA Pharmacokinetics in MASH Mice

  2026-09-22

  The reference study integrates pharmacokinetics, tissue distribution, cellular transport, and metabolic-enzyme analysis to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids. Its findings indicate that disease state and repeated dosing can increase systemic and hepatic exposure, providing a mechanistic basis for more rational dose design in MASLD/MASH research.

• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-09-22

  Use α-Bungarotoxin as a high-affinity α7 nAChR antagonist to separate receptor-dependent cholinergic effects from downstream toxicity, inflammation, and cell-death signals. This practical workflow connects classical neuroscience experiments with the placental necroptosis model reported in recent research.

• Pyridostigmine, Placental Necroptosis, and α7 nAChR

  2026-09-21

  This study identifies placental necroptosis as a modifiable feature of preeclampsia-like disease in rats and links pyridostigmine activity to α7 nicotinic acetylcholine receptor signaling. Its combined human tissue, RUPP rat, antagonist, inhibitor, and trophoblast-cell experiments provide a mechanistic framework for studying non-neuronal cholinergic regulation of placental ischemic injury.

• BMS 599626 dihydrochloride Workflow Guide

  2026-09-21

  Build reproducible EGFR/HER2 phosphorylation, proliferation, and senescence-adjacent assays with BMS 599626 dihydrochloride. This workflow distinguishes direct receptor inhibition from downstream cell-state effects and translates machine-learning-guided senolytic discovery into practical experimental design.

• Separating Growth Inhibition from Cell Death In Vitro

  2026-09-20

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measurements capture different relationships between proliferative arrest and drug-induced cell death. The framework provides a practical basis for designing time-aware cancer drug assays and avoiding overinterpretation of a single viability endpoint.

8071 records 1/539 page Next 12345 下5页 Last page